According to Intercept Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is $6.39. In 2022 the company made an earnings per share (EPS) of $6.47 an increase over its 2021 EPS that were of -$2.89.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $6.39 | -1.24% |
2022 | $6.47 | -323.88% |
2021 | -$2.89 | -65.47% |
2020 | -$8.37 | -23.14% |
2019 | -$10.89 | -0.55% |
2018 | -$10.95 | -23.91% |
2017 | -$14.39 | -14.04% |
2016 | -$16.74 | 76.4% |
2015 | -$9.49 | -33.78% |
2014 | -$14.33 | 290.46% |
2013 | -$3.67 | -29.37% |
2012 | -$5.20 |